The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia
BACKGROUND: Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) infections; however, treatment failure is not uncommon, even when the minimum inhibitory concentration (MIC) of the MRSA strain is within the susceptible range for vancomycin.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2013/585834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|